These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 23876336)
1. In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii. Thamlikitkul V; Tiengrim S Int J Antimicrob Agents; 2013 Sep; 42(3):284-5. PubMed ID: 23876336 [No Abstract] [Full Text] [Related]
2. Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex. Huang YS; Wang JT; Sheng WH; Chuang YC; Chang SC J Microbiol Immunol Infect; 2015 Oct; 48(5):545-51. PubMed ID: 24662017 [TBL] [Abstract][Full Text] [Related]
3. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Poirel L; Nordmann P Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287 [TBL] [Abstract][Full Text] [Related]
4. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. Metan G; Alp E; Aygen B; Sumerkan B J Antimicrob Chemother; 2007 Jul; 60(1):197-9. PubMed ID: 17540668 [No Abstract] [Full Text] [Related]
5. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model. Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761 [TBL] [Abstract][Full Text] [Related]
6. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea. Park YK; Jung SI; Park KH; Kim SH; Ko KS Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405 [TBL] [Abstract][Full Text] [Related]
7. Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain. Mugnier PD; Bindayna KM; Poirel L; Nordmann P J Antimicrob Chemother; 2009 May; 63(5):1071-3. PubMed ID: 19252183 [No Abstract] [Full Text] [Related]
8. Endemic carbapenem-resistant Acinetobacter baumannii in a Brazilian intensive care unit. dos Santos Saalfeld SM; Fukita Viana G; Dias Siqueira VL; Cardoso CL; Botelho Garcia L; Bronharo Tognim MC J Hosp Infect; 2009 Aug; 72(4):365-8. PubMed ID: 19541388 [No Abstract] [Full Text] [Related]
9. Comparative in vitro activity of minocycline and selected antibiotics against carbapenem-resistant Acinetobacter baumannii from Thailand. Thamlikitkul V; Tiengrim S; Seenama C Int J Antimicrob Agents; 2016 Jan; 47(1):101-2. PubMed ID: 26725031 [No Abstract] [Full Text] [Related]
11. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946 [TBL] [Abstract][Full Text] [Related]
12. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia. Zheng YL; Wan YF; Zhou LY; Ye ML; Liu S; Xu CQ; He YQ; Chen JH Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521 [TBL] [Abstract][Full Text] [Related]
13. CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex. Akers KS; Barsoumian A; Beckius ML; Murray CK; Mende K Diagn Microbiol Infect Dis; 2010 Jun; 67(2):209-11. PubMed ID: 20466197 [No Abstract] [Full Text] [Related]
14. Carbapenem-resistant Acinetobacter baumannii infections after organ transplantation. Reddy P; Zembower TR; Ison MG; Baker TA; Stosor V Transpl Infect Dis; 2010 Feb; 12(1):87-93. PubMed ID: 19735384 [TBL] [Abstract][Full Text] [Related]
15. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588 [TBL] [Abstract][Full Text] [Related]
16. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070 [No Abstract] [Full Text] [Related]